Lilium (NASDAQ:LILM – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a report issued on Monday, Benzinga reports. They currently have a $2.00 target price on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 171.00% from the company’s current price.
Separately, Canaccord Genuity Group reiterated a “buy” rating and set a $2.00 target price on shares of Lilium in a report on Thursday, June 27th.
View Our Latest Analysis on LILM
Lilium Stock Performance
Institutional Investors Weigh In On Lilium
A number of large investors have recently modified their holdings of the company. Longitude Cayman Ltd. increased its position in shares of Lilium by 12.2% in the 2nd quarter. Longitude Cayman Ltd. now owns 1,514,672 shares of the company’s stock valued at $1,204,000 after purchasing an additional 164,672 shares during the last quarter. RS Crum Inc. purchased a new stake in shares of Lilium in the 2nd quarter valued at approximately $328,000. Quadrature Capital Ltd purchased a new stake in shares of Lilium in the 4th quarter valued at approximately $280,000. Freestone Capital Holdings LLC purchased a new stake in shares of Lilium in the 1st quarter valued at approximately $55,000. Finally, Financial Designs Corp purchased a new position in shares of Lilium in the 2nd quarter valued at $32,000. 8.30% of the stock is owned by hedge funds and other institutional investors.
About Lilium
Lilium N.V. engages in the research and development of electric vertical takeoff and landing aircrafts and jet for use in high-speed air transport system for people and goods. It also provides aircraft manufacturer services, including training services, maintenance operations, material management and global distribution, flight operations support, ground service equipment, and digital solutions.
Featured Stories
- Five stocks we like better than Lilium
- What Do S&P 500 Stocks Tell Investors About the Market?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Does Downgrade Mean in Investing?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Industrial Products Stocks Investing
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Lilium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lilium and related companies with MarketBeat.com's FREE daily email newsletter.